Authors: Elkhatib, W.F.; Haynes, V.L.; Noreddin, A.M.

Source: Journal of Chemotherapy, Number 2, April 2009 , pp. 135-143(9)

Publisher: Maney Publishing

Abstract:

Chronic multi-drug resistant Pseudomonas aeruginosa infections among hospitalized elderly patients are nearly epidemic in some institutions and biofilms are now recognized as the root cause of such chronic infections such as with cystic fibrosis patients. We address the potential risks and advantages of combining commonly prescribed calcium channel blockers (CCBs) with the fluoroquinolone levofloxacin in the treatment of P. aeruginosa biofilms by using In Vitro real-time monitoring of biofilm growth/inhibition over time. While mibefradil and diltiazem appear to be strongly antagonistic toward antimicrobial activity of levofloxacin, amlodipine and bepridil appear to have significant synergistic effects.

Keywords: bepridil; levofloxacin; Pseudomonas aeruginosa; resistance; biofilm; calcium channel blocker; diltiazem

Document Type: Research Article

Publication date: 2009-04-01

More about this publication?

• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Top Articles
• Abstracted in
• Sign up for e-alerts
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• By this author: Elkhatib, W.F. ;  Haynes, V.L. ;  Noreddin, A.M.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers